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Abstract
Background: Stem cell transplantation as therapy for hematological disorders is often hampered
by severe graft-versus-host-disease. This may be reduced by umbilical cord blood transplantation,
an effect that has been attributed to qualitative differences between neonatal and adult T cells. We
compared levels of secreted proteins and cytokine mRNA induced in cord blood leukocytes (CBL)
and adult blood leukocytes (ABL) by various stimuli.
Results: While interleukin-2 (IL-2) levels were similar in CBL and ABL, there was less induction
of the Th1 cytokine interferon-γ in CBL. Production of the Th2 cytokines IL-4, IL-5, and IL-13 and
the hematopoietic cytokine IL-3 was much lower in CBL versus ABL after T-cell receptor-mediated
stimulation, whereas production of GM-CSF was comparable in the 2 cell types. The lower levels
of Th1 and Th2 cytokines were maintained in CBL during a 4-day time-course study, while after 12
hours IL-3 and GM-CSF reached in CBL levels similar to those in ABL. For all cytokines except
IFNγ, the IC50 values for inhibition by cyclosporin A were similar in ABL and CBL. In contrast, there
was less expression and activation of transcription factors in CBL. Activation of NF-κB by TPA/
ionomycin was detected in ABL but not CBL. Furthermore, there was less expression of the Th
subset-specific transcription factors T-bet and c-maf in CBL versus ABL, whereas GATA-3
expression was similar. Expression of T-bet and c-maf correlated with expression of the Th1 and
Th2 cytokines, respectively. Time course experiments revealed that T-bet expression was
stimulated in both cell types, whereas c-maf and GATA-3 were induced only in ABL.
Conclusion:  The diminished capability of CBL to synthesize cytokines is probably due to
decreased activation of NF-κB, whereas differences in Th subsets are due to differences in
regulation of Th lineage-specific transcriptions factors. We propose that the reduced incidence and
severity of GvHD after allogeneic transplantation of umbilical CB cells is due to lesser activation of
specific transcription factors and a subsequent reduction in production of certain cytokines.
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Background
Allogeneic stem cell transplantation (SCT) is an accepted
treatment for a variety of benign and malignant hemato-
logical disorders [1]. Successful SCT requires suitable
donors. These may be siblings, other family members, or
human leukocyte antigen (HLA)-matched unrelated indi-
viduals. Due to the complexity of the HLA system, donors
cannot be found for all patients needing a transplant.
Close matching confers a higher probability of successful
engraftment and minimizes the risk of potentially fatal
graft-versus-host disease. Unfortunately, there is only a
25% chance for identifying a full HLA match in a sibling
donor[2]. Therefore, interest has developed in potential
new sources of stem cells such as cord blood (CB), which
is rich in hematopoietic stem cells and precursor cells.
First experiences with this new stem cell source for clinical
transplantation showed that it can be used even in the
presence of major HLA disparities between recipients and
related or unrelated donors [3]. Despite major HLA differ-
ences, the graft failure rate and incidence and severity of
graft-versus-host disease (GvHD) are low [3,4]. The rea-
sons for this are still unknown. It is speculated that GvHD
is less severe because CB recipients receive fewer T cells
than do recipients of bone marrow or peripheral blood
(PB) stem cells and that cord blood lymphocytes (CBL)
are more immature and not yet sensitized to HLA antigens
[5]. However, there may be inherent differences in the
composition and functional activity of lymphocyte sub-
sets, and in antigen-presenting cells in CB and adult blood
(AB) [5,6]. The incidence and severity of GvHD may be
sensitive to not only factors relevant to transplantation
such as HLA compatibility, donor and recipient age, T-cell
inoculum, and the source of stem cells but also to the
effects of a number of cytokines. Therefore, it is important
to investigate whether differences in cytokine production
between CB and AB can account in part for the reduced
incidence of graft versus host disease with CB transplanta-
tion.
A variety of experimental techniques, including enzyme-
linked immunosorbent assay (ELISA) and bioassays, have
been used to measure cytokine secretion by CB cells and
AB cells. Unfortunately, these studies have produced lim-
ited and inconclusive results [7,8]. Reduced production of
intracellular interleukin-2 (IL-2), IL-4, tumor necrosis fac-
tor-α (TNF-α), and interferon-γ (IFN-γ) was detected by
flow cytometry in phorbol 12-myristate 13-acetate-acti-
vated and ionomycin-activated CBL compared with ABL
[9]. ELISA demonstrated that purified CD4+CD45RA+
cells from CB produce only 10% of the amount of IL-2
produced by cells from AB. It was hypothesized that this
may play a crucial role in the reduced development of
GvHD with CB transplantation [10].
To overcome the inherent problems of previously used
techniques we investigated cytokine production in CB and
AB using real-time RT-PCR. We quantified mRNA expres-
sion and protein levels of a number of Th1, Th2, and
hematopoietic cytokines synthesized in response to a vari-
ety of T-cell stimuli. In addition, we quantitatively ana-
lyzed the activation and expression of relevant T-cell
transcription factors.
Results
Analysis of cell populations
Consistent with previous reports, there were higher total
leukocyte counts in CB versus AB [9]. Total leukocyte
counts ranged from 5,200 to 9,800/mm3 in ABL and from
11,400 to 22,700/mm3 in CBL. We also determined the
numbers of cells expressing CD3, CD4, CD28, and CD45
in mononuclear cell preparations from AB and CB (Table
1). There were a slightly higher number of CD3+ cells in
ABL than CBL, whereas the numbers of CD4+ cells were
similar. Double-staining showed that all CD4+ cells were
also CD3+. CBL had a smaller proportion of CD3+ cells
that were not CD4+ than did ABL, indicating lower num-
bers of CD8+ cells in CBL. CD28 was similarly expressed
in CBL and ABL. Almost all CD3+ cells were also CD28+.
Consistent with previous reports, CBL contained very few
CD45RO+ cells; there were greater numbers in ABL. There
were similar numbers of CD45RA+ cells in ABL and CBL.
CBL and ABL cytokine responses to stimuli
Since CBL and ABL similarly expressed the cell surface
receptors CD3 and CD28, which transduce activation sig-
nals from the cell surface to the interior, we analyzed the
responses of CBL and ABL to different stimuli. Mitogenic
substances and antibodies stimulating surface receptors
were used in different combinations, and the induction of
various cytokines was measured by quantitative real-time
RT-PCR and ELISA. TPA and ionomycin were chosen
because they act synergistically and are able to bypasses
Table 1: Distribution of surface antigens on CBL and ABL
% Positive CD3+ CD4+ CD4+/CD3+ CD28+ CD3+/CD28+ CD45RA+ CD45RO+
CBL 25.6 ± 2.9 18.7 ± .2 100.0 ± 0.1 24.7 ± 2.8 96.6 ± 1.8 41.3 ± 5.2 1.1 ± 0.3
ABL 30.1 ± 4.1 17.8 ± 2.2 99.7 ± 0.5 27.8 ± 4.2 91.3 ± 4.6* 45.3 ± 3.6 11.6 ± 2.8**
Mononuclear cells were isolated from whole blood by density gradient centrifugation over Histopaque 1077. The numbers of positive cells were 
determined by 1 or 2-color FACS analysis and are expressed as the percent of positive cells among total leukocytes. Data are mean ± standard 
error for 9 donors. *p < 0.05 ABL vs. CBL. **p < 0.01 ABL vs. CBL.BMC Immunology 2007, 8:18 http://www.biomedcentral.com/1471-2172/8/18
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the requirement for antigen- or lectin-induced signal at
the onset of lymphocyte activation [11]. CD3- and CD28-
antibodies were chosen, because they are able to mimick
the two signals needed for antigen specific avtivation of T-
Cells.
Th1 cytokines
For the Th1 cytokines IL-2 and IFNγ a combination of the
mitogenic stimuli TPA and ionomycin caused the highest
induction of mRNA and protein in both ABL and CBL (Fig
1). These mitogenic stimuli induced similar levels of IL-2
mRNA and protein in ABL and CBL. In contrast, stimula-
tion of cell surface receptors was approximately 10-fold
less effective in inducing expression of Th1 cytokines in
CBL versus ABL. Only with combinations including at
least one mitogenic stimulus Th1 cytokine levels were
raised to a similar degree in CBL as in ABL. This difference
was most pronounced for IFNγ; regardless of the stimulus
applied, CBL produced less IFNγ protein. In CBL, IFNγ
protein was induced only by combined stimulation with
TPA and ionomycin, and at far lower levels than in ABL.
Th2 cytokines
Induction of the IL-4, IL-5, and IL-13 was assessed by real-
time RT-PCR and ELISA, as described above (Fig 2). High-
est induction of IL-4 in both cell types was observed, when
ionomycin was present as stimulus. However, the levels of
IL-4 were lower in CBL than in ABL. α-CD3 and α-CD28
induced moderately IL-4 mRNA and protein in ABL but
were rather inefficient in CBL. IL-5 mRNA level were close
to the dectection limit and IL-5 protein was barely detect-
able in CBL, whereas a combination of any two stimuli
induced detectable amounts of IL-5 in ABL. In CBL, IL-13
mRNA and protein were induced only with the applica-
tion of at least one mitogenic stimulus, whereas in ABL
there was little difference in the level of IL-13 induction
with different stimuli. However, similar or even higher
Induction of Th1 cytokine mRNA and protein in ABL and CBL Figure 1
Induction of Th1 cytokine mRNA and protein in ABL and CBL. mRNA levels (A, B) were determined using real-time RT-PCR 
after 4 hrs of stimulation. Data are expressed as arbitrary units normalized to β-actin to correct for RNA quantity and integ-
rity. The dotted line indicates the basal mRNA level of untreated cells. Protein levels (C, D) were determined in the superna-
tant by ELISA after 24 hrs of stimulation. Bars are mean ± standard error for 3 donors. Similar results were obtained in 3 
independent experiments. Although there was a clear coinciding tendency in all experiments, individual differences between 
blood samples often reduced the significance of the differences between CB and AB. Iono – Ionomycin. *p < 0.05, **p < 0.01 
ABL vs. CBL.BMC Immunology 2007, 8:18 http://www.biomedcentral.com/1471-2172/8/18
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levels of IL-13 mRNA and protein were detected in CBL
compared to ABL.
Hematopoietic cytokines
CB and AB differ in their poietic and bone marrow repop-
ulating capacities [12]. Therefore, we evaluated CBL and
ABL production of the hematopoietic cytokines IL-3 and
GM-CSF (Fig 3). The strongest induction of IL-3 mRNA
and protein occurred in the presence of ionomycin. α-
CD3 and α-CD28 more potently stimulated IL-3 mRNA in
ABL versus CBL. GM-CSF was the only cytokine for which
there were no significant differences in mRNA or protein
between ABL and CBL. Mitogenic stimuli induced much
higher levels of GM-CSF protein than did stimulation of
surface receptors alone.
Kinetics of cytokine production
Differences in cytokine expression between ABL and CBL
may stem from different induction kinetics. Therefore, we
analyzed levels of cytokine mRNA at a series of time
points up to 4 days after stimulation. Since the combina-
tion of TPA and ionomycin induced detectable levels of all
cytokines, regardless of differences in receptor expression,
we focused on this stimulus. Because the kinetics were
similar within each group of cytokines (Th1, Th2, and
hematopoietic cytokines), only data from one cytokine in
each group is shown in Figure 4. mRNA levels of the Th1
cytokines IL-2 and IFNγ peaked 6 hrs after stimulation in
ABL and 24 hrs after stimulation in CBL (Fig 4A). Levels
remained nearly constant for the remainder of the obser-
vation period. At each time point mRNA expression was
approximately one order of magnitude greater in ABL ver-
sus CBL. This difference was significant at 2,6, 12 and 48
hours. On day 4, mRNA levels declined in ABL, whereas
levels increased slightly in CBL reaching similar levels as
in ABL.
In contrast to these patterns, mRNA levels for the Th2
cytokines IL-4, IL-5, and IL-13 peaked between 2–6 hrs
then steadily declined (Fig 4B). The levels of IL-4 and IL-5
expression were approximately 2 orders of magnitude
higher in ABL versus CBL, and the level of IL-13 expres-
sion was approximately one order of magnitude higher in
ABL versus CBL. This difference was significant at evey
time point except 24 hours.
Patterns of expression of the hematopoietic cytokines IL-
3 and GM-CSF were remarkably different. In CBL, the
Induction of Th2 cytokine mRNA and protein in ABL and CBL Figure 2
Induction of Th2 cytokine mRNA and protein in ABL and CBL. mRNA levels (A, B, C) were determined using real-time RT-
PCR after 4 hrs of stimulation. Data are expressed as arbitrary units normalized to β-actin to correct for RNA quantity and 
integrity. The dotted line indicates the basal mRNA level of untreated cells. Protein levels (D, E, F) were determined in the 
supernatant by ELISA after 24 hrs of stimulation. Bars are the mean ± standard error for 3 donors. Similar results were 
obtained in 3 independent experiments. Iono – Ionomycin. *p < 0.05, **p < 0.01 ABL vs. CBL.BMC Immunology 2007, 8:18 http://www.biomedcentral.com/1471-2172/8/18
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kinetics of IL-3 and GM-CSF expression were delayed;
mRNA levels peaked at 12 hrs (Fig 4C). In contrast, in
ABL, after an initial increase in mRNA levels between 0
and 6 hrs, levels were reduced at 12 hrs but thereafter
increased again, peaking after 48 hrs. IL-3 levels in ABL
and CBL were similar after 12 hrs but differed before and
after this time point. Remarkably, this is the only time
point at which levels of expression of any of the cytokines
were comparable for CBL and ABL. IL-3 levels were only
significantly different at 2 and 48 hours.
Sensitivity of ABL and CBL to CsA
CsA is a potent inhibitor of various T-cell-derived
cytokines. It is an effective prophylactic and treatment for
GvHD. Therefore, we investigated possible difference in
dose-responsiveness of ABL and CBL to CsA. Cells were
preincubated with different concentrations of CsA and
subsequently stimulated with a combination of TPA and
ionomycin. Table 2 shows the IC50 of production of
cytokine protein after a 24-hr stimulation period. Results
from mRNA expression after a 6-hr stimulation period
were comparable to the IC50s for cytokine protein inhibi-
tion after 24 hours (data not shown). All cytokines were
Table 2: IC50 values for the inhibition of cytokine protein 
synthesis by CsA in ABL and CBL
Cytokine CBL (nM) ABL (nM)
IL-2 4.52 ± 0.70 3.36 ± 0.13
IFNγ 4.32 ± 0.89 12.60 ± 5.05
IL-4 3.43 ± 0.68 3.71 ± 0.16
IL-5 3.27 ± 0.91 4.73 ± 1.23
IL-13 4.42 ± 0.67 3.74 ± 0.06
IL-3 3.20 ± 0.41 5.56 ± 1.03
GM-CSF 7.75 ± 0.53 9.02 ± 0.44
Cells were stimulated by TPA/ionomycin for 24 hrs. Protein levels 
were determined in the supernatant by ELISA. Data shown are mean 
IC50 ± standard error for 3 donors.
Induction of hematopoietic cytokine mRNA and protein in ABL and CBL Figure 3
Induction of hematopoietic cytokine mRNA and protein in ABL and CBL. mRNA levels (A, B) were determined using real-time 
RT-PCR after 4 hrs of stimulation. Data are expressed as arbitrary units normalized to β-actin to correct for RNA quantity and 
integrity. The dotted line indicates the basal mRNA level of untreated cells. Protein levels (C, D) were determined in the 
supernatant by ELISA after 24 hrs of stimulation. Bars are the mean ± standard error for 3 donors. Similar results were 
obtained in 3 independent experiments. Iono – Ionomycin. *p < 0.05, **p < 0.01 ABL vs. CBL.BMC Immunology 2007, 8:18 http://www.biomedcentral.com/1471-2172/8/18
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sensitive to inhibition by CsA in both ABL and CBL. The
IC50 values ranged between 3 and 10 nM and did not dif-
fer significantly between cytokines or cell sources.
Activation of transcription factors in ABL and CBL
Since there was reduced cytokine protein and mRNA
expression in CBL, we investigated whether the expression
of transcription factors is also reduced in CBL. First, we
assessed the activation of the more general transcription
factor nuclear factor-kappa B (NF-κB). We determined the
DNA-binding activity of NF-κB subunit p50 in nuclear
extracts using ELISA of DNA-bound transcription factor
molecules. As shown in Figure 5, the basal activity of NF-
κB was similar in ABL and CBL. TPA and ionomycin stim-
ulated NF-κB activity in ABL, whereas hardly any increase
in activity was detected in CBL. α-CD3/α-CD28 stimula-
tion did not affect the activity of NF-κB in either cell type.
Expression of transcription factors in ABL and CBL
Since there was deficient production of Th2 cytokines in
CBL, we determined whether CBL and ABL differently
expressed Th subset-specific transcription factors.
Recently, T-bet was described as a Th1-specific transcrip-
tion factor. Since no antibodies against human T-bet were
available at the time of the study, we compared the mRNA
expression of T-bet in ABL and CBL exposed to various
stimuli (Fig 6A). There was a specific defect in T-bet
expression in CBL after antigenic stimulation. Following
TPA stimulation, expression levels were similar in ABL
and CBL, and the pattern of expression mirrored that for
Activity of transcription factors Figure 5
Activity of transcription factors. Nuclear extracts were pre-
pared 60 min after stimulation. NF-κB p50 DNA binding 
activity was determined by ELISA as described in the Materi-
als and Methods. The optical density (O.D.) was detected at 
655 nm. Each bar represents the mean ± standard error for 3 
donors. **p < 0.01 ABL vs. CBL.
Kinetics of cytokine induction after stimulation with TPA and  ionomycin Figure 4
Kinetics of cytokine induction after stimulation with TPA and 
ionomycin. ABL and CBL were harvested at different time 
points by lysing cells. mRNA levels for IFNγ (A), IL-4 (B), and 
IL-3 (C) were determined as in Figure 1. Data points are the 
mean ± standard error for 6 donors. *p < 0.05, **p < 0.01 
ABL vs. CBL.BMC Immunology 2007, 8:18 http://www.biomedcentral.com/1471-2172/8/18
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Th1 cytokines (Fig 1). This is shown by the significant cor-
relation between expression of T-bet and IFNγ (r2 = 0.68;
p < 0.0001) but not IL-4 (r2 = 0.01) (Fig 6A). In contrast,
expression of c-maf, which has been described as a Th2-
specific transcription factor, mirrored that of Th2
cytokines (Fig 6B). There was a significant correlation
between expression of c-maf and IL-4 (r2 = 0.76, p  <
0.0001), but no significant correlation with IFNγ ( r2 =
0.02). c-maf expression was induced only by ionomycin
only in ABL (Fig 6B). Expression of GATA-3, another Th2-
specific transcription factor, did not correlate significantly
with IL-4 or IFNγ expression (Fig 6C). There was no signif-
icant difference in induction of this transcription factor in
CBL versus ABL, suggesting no immediate function of
GATA-3 in the defective cytokine production in CBLs (Fig
6C).
We also studied the time course of expression of transcrip-
tion factors after TPA/ionomycin stimulation. T-bet
expression underwent a similar increase in ABL and CBL
during the first 6 hrs and started to decrease after 24 hrs
(Fig 7A). Levels were only slightly lower in CBL versus
ABL. In contrast, TPA/ionomycin increased the expression
of c-maf and GATA-3 only in ABL, whereas levels in CBL
remained almost constant (Fig 7B,C). In ABL, the time
course of expression was similar to that for T-bet: a rapid
increase during the first 6 hrs and a decrease after 1 day.
Discussion
Because neonates are in a tolerizing status and adults are
not, it has been widely assumed that neonatal and adult T
cells differ qualitatively. However, recent findings have
generated debate regarding the differences between neo-
natal and adult T cells and whether they are quantitative
or due in part to differences in cytokine production. In
this study, we examined the induction of cytokine mRNA
and protein in human ABL and CBL. Different combina-
tions of mitogenic substances and antibodies stimulating
cell surface receptors induced the Th1, Th2, and hemat-
opoietic cytokines to a varying extent. Although there
were lower cytokine levels in CBL, they were not accom-
panied by resistance to the immunosuppressive com-
pound CsA, commonly used in bone marrow
transplantation. Differences in the ability of ABL and CBL
to produce cytokines are likely due to reduced activation
of transcription factors. Activation of NF-κB was greater in
ABL versus CBL. Expression of T-bet and c-maf correlated
with expression of the Th1 and Th2 cytokines, respec-
tively. Time course experiments revealed that T-bet expres-
sion was stimulated in both cell types, whereas c-maf and
GATA-3 were induced only in ABL.
Comparison of cytokine production 24 hrs after stimula-
tion revealed comparable induction of IL-2 in ABL and
CBL. In contrast, induction of the prototypic Th1 cytokine
Induction of transcription factors in ABL and CBL after stim- ulation for 4 hrs Figure 6
Induction of transcription factors in ABL and CBL after stim-
ulation for 4 hrs. mRNA levels of T-bet (A), GATA-3 (B), and 
c-maf (C) were determined using real-time RT-PCR. Data 
are expressed as arbitrary units normalized to β-actin to cor-
rect for RNA quantity and integrity. Columns are the mean ± 
standard for 3 donors. The inset shows the correlation 
between expression of the respective transcription factor 
with IFNγ and IL-4. Dotted line indicates basal transcript lev-
els. Iono – Ionomycin.BMC Immunology 2007, 8:18 http://www.biomedcentral.com/1471-2172/8/18
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IFNγ was much weaker in CBL, regardless of the stimulus.
Even bypassing the T-cell receptor with mitogenic stimuli
failed to induce similar levels of IFNγ in CBL and ABL.
The optimal induction stimuli differed for the various Th2
cytokines. IL-4 was efficiently induced only in the pres-
ence of ionomycin. The importance of this stimulus for IL-
4 was demonstrated previously [13,14]. IL-5 was induced
only in the presence of two stimuli. Following most stim-
uli, IL-4 and IL-5 protein were not detectable in CBL. In
contrast, in the presence of mitogenic stimuli, IL-13
reached levels in CBL that were comparable to those in
ABL.
It was previously reported that Th2 cells outnumber Th1
cells in neonates [15,16]. However, we found lower
expression of both Th1 and Th2 cytokines in CBL versus
ABL and no changes in the relation of Th1 and Th2
cytokines between ABL and CBL. Other studies used intra-
cellular staining of cytokines to detect differences between
ABL and CBL after stimulation with TPA/ionomycin. In
agreement with our data, these studies reported similar
levels of intracellular IL-2 in the two cell types and lower
levels of IFNγ and IL-4 in CBL versus ABL [9,17]. Thus, the
imbalance of these T cell subsets cannot be ascribed solely
to levels of cytokine production.
IL-3 expression was greater in ABL than CBL, regardless of
the stimulus. Interestingly, GM-CSF reached similar levels
in ABL and CBL with most stimuli applied. Surface recep-
tor stimulation remained ineffective, whereas the pres-
ence of mitogens efficiently induced this cytokine.
Although neither a precise mechanism nor a physiological
influence of IL-3 on early hematopoietic processes is
known, several lines of evidence suggest that IL-3 inhibits
T and B lymphopoietic events and therefore should lead
to reduced appearance of GvHD [18]. This hypothesis
conflicts with our finding of reduced IL-3 production in
CBL. However, there is some in vivo and in vitro evidence
that underlines the limited proliferation and differentia-
tion activities of IL-3, compatible with a reduced potential
to repopulate stem cells. In this context, reduced produc-
tion of IL-3 may be beneficial for stem cell engraftment
and bone marrow repopulation in CBL transplant
patients.
Since our first series of experiments investigated only 1
time point, we investigated the possibility that differences
in the capability of ABL and CBL to produce various
cytokines are due to differences in induction kinetics.
MRNA levels for all cytokines remained at least 10-fold
lower in CBL during the whole period. The only exception
is IL-3, whose level of expression remained similar in CBL
and ABL after 12 hrs. Chalmers et al. used intracellular
staining and flow cytometry to analyze the number of
Time course of transcription factor induction after stimula- tion with TPA and ionomycin Figure 7
Time course of transcription factor induction after stimula-
tion with TPA and ionomycin. ABL and CBL were harvested 
at different time points by lysing cells. mRNA levels were 
determined for T-bet (A), GATA-3 (B), and c-maf (C). Data 
points are mean ± standard error for 6 donors. *p < 0.05 
ABL vs. CBL.BMC Immunology 2007, 8:18 http://www.biomedcentral.com/1471-2172/8/18
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cells producing IL-2, IL4, and IFNγ during a time period of
24 hrs. They found similar numbers of cells producing IL-
2 in ABL and CBL, but smaller numbers of cells producing
IL-4 and IFNγ in CBL [9].
The lower cytokine levels in CBLs did not lead to drug
resistance against the immunosuppressive CsA, which is
commonly used in bone marrow transplantation. All
cytokines were sensitive to inhibition by CsA, with similar
IC50 values for ABL and CBL. Also, no difference between
protein and mRNA levels was found. An IC50 of 10 nM
was reported for IL-2 in ABL [19]. McDouall et al. reported
greater sensitivity of IL-2-dependent cell proliferation to
CsA in CBL [20]. However, they found only minor differ-
ences at low CsA concentrations. Furthermore, another
study did not find any significant difference in the sensi-
tivity of T-cell effector functions to CsA [21]. Overall,
these findings suggest that the benefits of CBL for bone
marrow transplantation are probably not due to increased
drug resistance to CsA.
Since we found no difference in expression of the CD3
and CD28 receptor molecules in CBL, we investigated
whether differences in cytokine expression of ABL and
CBL are due to differences in the expression or activation
of transcription factors. We showed for the first time that
the overall reduced cytokine synthesis in CBL can be
explained at least in part to lesser activation of the tran-
scription factor NF-κB. The importance of this transcrip-
tion factor to the activation of a number of T cell cytokines
such as IL-2, IL-4, IFNγ, IL-3, and GM-CSF has been previ-
ously described [22]. Similarly, it has been shown that
expression of NFAT1 protein is significantly lower in CB T
cells versus adult T cells and is only partially expressed
after prolonged primary T-cell receptor stimulation [23].
The lack of activation of NF-κB by CD3/CD28 stimulation
can be explained by a slower kinetic of NF-κB activation
as compared to TPA/ionomycin stimulation [24].
T-bet has been described as a Th1-inducing transcription
factor that activates expression of IFNγ [25], whereas c-
maf is responsible for tissue-specific expression of the Th2
cytokine IL-4 [26]. We found that the expression of these
Th subset-specific transcription factors was regulated by a
variety of stimuli. TPA/ionomycin evoked a tremendous
upregulation of T-bet. Furthermore, expression of T-bet
was higher in ABL versus CBL. Only mitogenic stimuli
induced comparable levels in CBL. This pattern mirrors
the expression of Th1 cytokines such as IFNγ, as corrobo-
rated by the significant correlation between expression of
T-bet and IFNγ. In contrast, the Th2 subset-specific tran-
scription factor c-maf was regulated mainly by ionomycin.
Ionomycin was effective only in ABL, suggesting a specific
defect in calcium signaling in CBL, which may be respon-
sible for the lower expression of Th2 cytokines. We found
a significant correlation between the expression of c-maf
and IL-4 but not IFNγ. Ionomycin's ability to effectively
stimulate IL-4 has been described previously [13]. The
expression of another Th2-specific transcription factor,
GATA-3, does not seem to be regulated.
TH-cell differentiation is found to be mediated by lineage-
specific transcription mechanisms. IL-12 regulates TH1-
cell differentiation by activating the transcription factor
signal transducer and activator of transcription 4
(STAT4)[27]. Signalling cascades induced by TCR
crosslinking and IL-12 eventually lead to expression of the
transcription factor T-bet, which is a master regulator of
TH1-cell differentiation because it potentiates the produc-
tion of IFN γ and suppresses the expression of TH2
cytokines[27]. By contrast, IL-4 drives TH2-cell differentia-
tion through the action of STAT6[28], which upregulates
expression of GATA-binding protein 3 (GATA3), a master
regulator of TH2-cell differentiation that is both necessary
and sufficient for TH2-cell development[29]. In addition,
c-maf, which was identified as the first TH2-cell-specific
transcription factor that binds the Il4 proximal promoter,
has an important role in IL-4 production once the TH2-cell
programme has been established[30]. Altogether we pro-
pose that the differences in cytokine production by Th1
and Th2 subsets can be explained by differences in the
expression of the subset-specific transcription factors T-
bet and c-maf. However, alternative explanations such as
differences in the expression of signal transduction mole-
cules do exist.
Time-course study of the expression of all transcription
factors after stimulation by TPA/ionomycin revealed
remarkable differences. Expression of T-bet was similar in
ABL and CBL. In contrast, c-maf and GATA-3 were only
induced in ABL, whereas the expression levels remained
nearly constant in CBL. This observation is consistent with
the results of the analysis of cytokine production, where
the difference in cytokine levels between CBL and ABL was
much greater for Th2 cytokines versus Th1 cytokines. This
correlation corroborates our hypothesis that the different
expression of Th subset specific transcription factors may
be responsible for the different cytokine expression level
in ABL and CBL.
Conclusion
This study investigated differences in cytokine production
by ABL and CBL and found a generally reduced capability
of CBL to produce cytokines. Because it is widely accepted
that T-cell mediated cytokine production plays a crucial
role in GvHD, we propose that reduced cytokine produc-
tion in CBL may contribute to a lower occurrence of
GvHD. This effect is due not to differences in populations
of memory and naive T cells, but may be due to lesser acti-
vation of transcription factor NF-κB. Differences inBMC Immunology 2007, 8:18 http://www.biomedcentral.com/1471-2172/8/18
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cytokine production by Th1 and Th2 subsets can be
explained by differences in the expression of the subset-
specific transcription factors T-bet and c-maf. Since no dif-
ferences in CsA sensitivity were found, it appears that the
reduced incidence and severity of GvHD after allogeneic
transplantation of umbilical CB cells is due to lesser acti-
vation of specific transcription factors and a subsequent
reduction in production of certain cytokines.
Methods
Materials
Oligonucleotides were synthesized by TIB Molbiol (Ber-
lin, Germany). DMSO, 2-O-tetradecanoylphorbol-13-ace-
tate (TPA), ionomycin, and Histopaque-1077 were
purchased from Sigma (Deisenhofen, Germany).
Cyclosporin A (CsA) was purchased from CALBIOCHEM
(San Diego, CA, USA). Purified anti-human CD3 and
purified anti-human CD28 were obtained from PharMin-
gen Becton Dickinson Company (Heidelberg, Germany).
RPMI 1640 medium was purchased from Life Technolo-
gies (Paisley Scotland). Unless otherwise indicated, all
other chemicals were purchased from Sigma Chemical
Company.
Cells
Heparinized peripheral blood samples were obtained
from healthy volunteers (9 men and 7 women ranging in
age from 22 to 55 years without medication for at least 14
days). Cord blood was obtained from the umbilical vein
immediately after vaginal delivery of uncomplicated preg-
nancies. This study was approved by the local ethics com-
mittee. Mononuclear cells were isolated by density
gradient centrifugation over Histopaque 1077 (Sigma,
Deisenhofen, Germany), washed twice in RPMI 1640
(Life Technologies), and resuspended in medium supple-
mented with 10% fetal calf serum (Life Technologies) as
described previously [31].
For study of cytokine production, ABL or CBL were resus-
pended at 106 cells/ml and incubated in 500 µl volumes
in 24-well tissue culture plates (Falcon Becton Dickinson
Labware) at 37°C with 5% CO2. Cells were stimulated
with soluble anti-CD3 monoclonal antibody (1 µg/ml),
anti-CD28 monoclonal antibody (0.3 µg/ml), TPA (25
ng/ml), ionomycin (1 µM), or combinations thereof [31].
At the times indicated, cells were sedimented by centrifu-
gation. The supernatants were harvested and kept frozen
at -80°C until determination of cytokine protein. The cells
were lysed by RLT lysis Buffer (QIAGEN) and frozen at -
80°C until RNA isolation. ELISA was performed as
described by the manufacturer (Pharmingen, Heidelberg,
Germany).
Monoclonal antibodies and flow cytometry
ABL and CBL were stained according to standard proce-
dures. Briefly, 5 × 105 cells were incubated in 200 µl FACS
buffer (1× PBS containing 0.5% fetal calf serum, 0.1%
NaN3, and 0.1 M glucose) with the respective monoclonal
antibodies for 30 min at room temperature. Subse-
quently, cells were washed twice with FACS buffer and
subjected to phenotypic analysis in a flow cytometer
(FACScan, Becton Dickinson). A minimum of 10,000
lymphocyte-gated events were acquired and analyzed
with CellQuest 4.0 software. FITC- or PE-conjugated mon-
oclonal anti-CD3, anti-CD4, anti-CD28, anti-CD45RA,
anti-CD14, anti-CD19, and anti-CD45RO antibodies
were used (Pharmingen, Heidelberg, Germany).
Quantitation of mRNA expression
RNA was prepared from frozen lysates using RNeasy from
QIAGEN (Hilden, Germany). One-tube RT-PCR was per-
formed using the TaqMan EZ RT-PCR kit from PE Applied
Biosystems (Weiterstadt, Germany). Expression of
cytokines was determined in relation to the expression of
β-actin by real-time PCR using a TaqMan assay on an ABI
Prism 7700. Primers and probes are listed in Table 3. For
each RT-PCR, the threshold cycle (CT) was determined,
defined as the cycle at which the fluorescence exceeds 10
times the standard deviation of the mean baseline emis-
sion during cycles 3–10. Cytokine mRNA levels were nor-
malized to the housekeeping gene β-actin according to the
following formula: ∆CT = CT
β-actin - CT
cytokine. Results are
Table 3: Primer and probes used for real-time RT-PCR









IL-3 GCTCCCATGACCCAGACAAC GGCAGACATGGCAGGAGATT AGCTGGGTTAACTGCTCTAACATGATCGATG
AAA
IL-4 CCCCCTCTGTTCTTCCTGCT AGCCCTGCAGAAGGTTTCCT TGCCGGCAACTTTGTCCACGG
IL-5 AGGATGCTTCTGCATTTGA TTCTATTATCCACTCGGTGTTC TATGCCATCCCCACAGAAATTCCCACA
IL-13 GGAGCTGGTCAACATCACCC CGTTGATCAGGGATTCCAGG CCAGAAGGCTCCGCTCTGCAATGGC
IFNγ CGAGATGACTTCGAAAAGCTGAC CGCTTCCCTGTTTTAGCTGC TCCAAGTGATGGCTGAACTGTCGCC
GM-CSF GCCCTGGGAGCATGTGAAT GCTCCAGGCGGGTCTGTAG AGGCCCGGCGTCTCCTGAACCTBMC Immunology 2007, 8:18 http://www.biomedcentral.com/1471-2172/8/18
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presented as 2∆CT based on the results of control experi-
ments yielding a PCR reaction efficiency of approximately
100%.
DNA binding activity of transcription factors
The DNA binding activity of transcriptions factors was
determined using the Transfactor system from Clontech
(Heidelberg, Germany). Nuclear extracts were prepared
from cells stimulated for 1 hr according to the manufac-
turer's protocol.
Statistical analysis
Data are expressed as mean ± standard error. Differences
were statistically analyzed using the unpaired Student's t-
test. IC50 values were calculated using PRISM 3.0 (Graph-
Pad Software Inc., San Diego, CA, USA).
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